futibatinib
otsuka
['futibatinib', 'taiho']
 announces updated efficacy, safety data for #futibatinib in #cholangiocarcinoma at 2022 #asco2022 annual meeting
#bileductcancer #biliarytractcancer #cholangiotwitter 
#LiverTwitter #CholangioTwitter #HPBCSM #BileDuctCancer breaking news.  Stage III T3 #intrahepatic #cholangiocarcinoma, NED since 05/29/2020. Word nerd ??